PD-L1 overexpression in solid tumors, including head and neck cancers [39], can provide direct tumor protection and reduce the activity of PD-1 expressing tumor-infiltrating effector CD8+ T cells [40,41]. The gene discussed is CD8A; the disease is head and neck cancer.